High affinity nanobodies against the Trypanosome brucei VSG are potent trypanolytic agents that block endocytosis.
The African trypanosome Trypanosoma brucei, which persists within the bloodstream of the mammalian host, has evolved potent mechanisms for immune evasion. Specifically, antigenic variation of the variant-specific surface glycoprotein (VSG) and a highly active endocytosis and recycling of the surface...
Guardado en:
Autores principales: | Benoît Stijlemans, Guy Caljon, Senthil Kumar A Natesan, Dirk Saerens, Katja Conrath, David Pérez-Morga, Jeremy N Skepper, Alexandros Nikolaou, Lea Brys, Etienne Pays, Stefan Magez, Mark C Field, Patrick De Baetselier, Serge Muyldermans |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a7f47e4a605e405ca7807a71666c3a46 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Nanobody-mediated macromolecular crowding induces membrane fission and remodeling in the African trypanosome
por: Alexander Hempelmann, et al.
Publicado: (2021) -
Trypanosoma brucei gambiense adaptation to different mammalian sera is associated with VSG expression site plasticity.
por: Carlos Cordon-Obras, et al.
Publicado: (2013) -
Development of a Nanobody-based lateral flow assay to detect active Trypanosoma congolense infections
por: Joar E. Pinto Torres, et al.
Publicado: (2018) -
Utilizing nanobody technology to target non-immunodominant domains of VAR2CSA.
por: Sisse B Ditlev, et al.
Publicado: (2014) -
THEORETICAL MODEL OF ALDOLASE FRUCTOSE 1,6 BIPHOSPHATE FROM Trypanosome brucei
por: CORDERO DE TROCONIS,MARYI, et al.
Publicado: (2010)